Hepatitis E virus

Reviews in Medical Virology

Volumn 17, Issue 3, 2007, Pages 151-180

  Panda, Subrat Kumar ^a   Thakral, Deepshi ^a   Rehman, Shagufta ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; CYSTEINE PROTEINASE; HELICASE; HEPATITIS E ANTIBODY; HEPATITIS VACCINE; METHYLTRANSFERASE; POLYPROTEIN; PROTEIN Y DOMAIN; PROTEINASE; RECOMBINANT CAPSID PROTEIN; RECOMBINANT HEPATITIS E VIRUS PROTEIN; REPLICASE; RNA DIRECTED RNA POLYMERASE; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG; VIRUS ENZYME;

AMINO ACID SEQUENCE; CELL CULTURE; CLINICAL FEATURE; CLINICAL TRIAL; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC HETEROGENEITY; GENOME ANALYSIS; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOELECTRON MICROSCOPY; INFECTION CONTROL; INFECTION PREVENTION; INTRAUTERINE INFECTION; LIVER DISEASE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PREGNANCY; PREVALENCE; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEROTYPE; TAXONOMIC IDENTIFICATION; VIREMIA; VIRUS CELL INTERACTION; VIRUS CLASSIFICATION; VIRUS EXAMINATION; VIRUS GENOME; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSCRIPTION; VIRUS TRANSMISSION; ZOONOSIS;

HEPATITIS E; HEPATITIS E VIRUS; HUMANS;

EID: 34249716343     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.522     Document Type: Review

References (272)

1. Yin S, Purcell RH, Emerson SU. A new Chinese isolate of hepatitis E virus: comparison with strains recovered from different geographical regions. Virus Genes 1994; 9: 23-32.
2. MacCallum FO. Homologous Serum Jaundice. Lancet 1947; 2: 691-692.
3. Feinstone SM, Kapikian AZ, Purceli RH. Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science 1973; 182: 1026-1028.
4. Blumberg BS, Alter HJ, Visnich S. A new antigen in leukemia sera. JAMA 1965; 191: 541-546.
5. Feinstone SM, Kapikian AZ, Purcell RH, Alter HJ, Holland PV. Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med 1975; 292: 767-770.
6. Wong DC, Purcell RH, Sreenivasan MA, Prasad SR, KMP. Epidemic and endemic hepatitis in India: evidence for a non-A//non-B hepatitis virus aetiology. Lancet 1980; 2: 876-879.
7. Vishwanathan R. Infectious hepatitis in Delhi (1955-56). A critical study: epidemiology. Indian J Med Res 1957; 45:49-58.
8. Khuroo MS. Study of an epidemic of non-A non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A non-B type. Am J Med 1980a; 6: 818-824.
9. Khuroo MS, Duermeyer W, Zargar SA, Ahanger MA, Shah MA. Acute sporadic non-A non-B hepatitis in India. Am J Epidemiol 1983; 118: 360-364.
10. Pavri K, Sreenivasan M, Gehgal A, Prasad S. Waterborne epidemics of non-A, non-B viral hepatitis in India. In Viral Diseases in South-East and the Western Pacific, Mackenzie JS (ed.). Academic Press: Sydney, 1982; 397-400.
11. Balayan MS, Andjaparidze AG, Savinskaya SS, et al. Evidence for a virus in non-A non-B hepatitis transmitted via the fecal-oral route. Intervirology 1983; 20: 23-31.
12. Reyes GR, Purdy MA, Kim JP, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non- A non-B hepatitis. Science 1990; 247: 1335-1339.
13. Hsieh SY, Meng XJ, Wu YH, et al. Identity of a novel swine hepatitis E virus in Taiwan forming a monophyletic group with Taiwan isolates of human hepatitis E virus. J. Clin Microbiol 1999; 37: 3828-3834.
14. Krawczynski K. Hepatitis E. Hepatology 1993; 17: 932-941.
15. Panda SK, Ansari IH, Durgapal H, Agrawal S, Jameel S. The in vitro-synthesized RNA from a cDNA clone of hepatitis E virus is infectious. J Virol 2000; 74: 2430-2437.
16. Zhang M, Purcell RH, Emerson SU. Identification of the 5′ terminal sequence of the SAR-55 and MEX-14 strains of hepatitis E virus and confirmation that the genome is capped. J Med Virol 2001; 65: 293-295.
17. Faquet C, Mayo M. The 7th ICTV Report. Arch Virol 2001; 146: 190-194.
18. Pringle C. Virus taxonomy-1999. The universal system of virus taxonomy, updated to include the new proposals ratified by the International Committee on Taxonomy of Viruses during 1998. Arch Virol 1999; 144: 421-429.
19. Feinstone S, Kapikian A, Purceli R. Hepatitis E: detection by immuneelectron microscopy of a virus like antigen associated with acute illness. Science 1973; 182: 1026-1028.
20. Miller M. Viral taxonomy. Clin Infect Dis 1995; 21: 279-280.
21. Kabrane-Lazizi Y, Zhang M, Purcell RH, Miller KD, Davey RT, Emerson SU. Acute hepatitis caused by a novel strain of hepatitis E virus most closely related to United States strains. J Gen Virol 2001; 82: 1687-1693.
22. Jiang X, Wang M, Wang K, Estes M. Sequence and genomic organization of Norwalk virus. Virology 1993; 195: 51-61.
23. Kabrane-Lazizi Y, Meng XJ, Purcell RH, Emerson SU. Evidence that the genomic RNA of hepatitis E virus is capped. J Virol 1999; 73: 8848-8850.
24. Tam AW, Smith MM, Guerra ME, et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 1991; 185: 120-131.
25. Purdy M, Tam A, Huang C, Yarbough P, Reyes G. Hepatitis E virus: a non-enveloped member of the 'alpha- like' RNA virus supergroup. Sem Virol 1993b; 4: 319-326.
26. Koonin EV, Gorbalenya AE, Purdy MA, Rozanov MN, Reyes GR, Bradley DW. Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses. Proc Natl Acad Sci USA 1992; 89: 8259-8263.
27. Berke T, Matson DO. Reclassification of the Caliciviridae into distinct genera and exclusion of hepatitis E virus from the family on the basis of comparative phylogenetic analysis. Arch Virol 2000; 145: 1421-1436.
28. Green K, Ando T, Balayan M, et al. Taxonomy of the caliciviruses. J Infect Dis 2000; 181: S322-S330.
29. Kane M, Bradley D, Shrestha S, et al. Epidemic non-A, non-B hepatitis in Nepal. Recovery of a possible etiologic agent and transmission studies in marmosets. JAMA 1984; 252: 3140-3145.
30. Bradley D, Krawczynski K, Cook EJ, et al. Enterically transmitted non-A, non-B hepatitis serial passage of disease in cynomolgus macaques and tamarins and recovery of disease-associated 27- to 34-nm viruslike particles. Proc Natl Acad Sci USA 1987; 84: 6277-6281.
31. Arankalle V, Ticehurst J, Sreenivasan M, et al. Aetiological association of a virus-like particle with enterically transmitted non-A, non-B hepatitis. Lancet 1988; 1: 550-554.
32. Bradley D, Andjaparidze A, Cook EH, Jr. et al. Aetiological agent of enterically transmitted non-A, non-B hepatitis. J Gen Virol 1988; 69: 731-738.
33. Ticehurst J, Popkin TJ, Bryan JP, et al. Association of hepatitis E virus with an outbreak of hepatitis in Pakistan: serologic responses and pattern of virus excretion. J Med Virol 1992; 36: 84-92.
34. Bradley D. Enterically-transmitted non-A, non-B hepatitis. Br Med Bull 1990; 46: 442-461.
35. Ticehurst J. Identification and characterization of hepatitis E virus. In Viral Hepatitis and Liver Disease, Hollinger B, Lemon S, Margolis H (eds). Williams and Wilkins: Baltimore, 1991; 501-513.
36. Zafrullah M, Khursheed Z, Yadav S, Sahgal D, Jameel S, Ahmad F. Acidic pH enhances structure and structural stability of the capsid protein of hepatitis E virus. Biochem Biophys Res Commun 2004; 313: 67-73.
37. He J, Tam AW, Yarbough PO, Reyes GR, Carl M. Expression and diagnostic utility of hepatitis E virus putative structural proteins expressed in insect cells. J Clin Microbiol 1993; 31: 2167-2173.
38. Ticehurst J, Rhodes LL Jr., Krawczynski K, et al. Infection of owl monkeys (Aotus trivirgatus) and cynomolgus monkeys (Macaca fascicularis) with hepatitis E virus from Mexico. J Infect Dis 1992; 165: 835-845.
39. Psichogiou MA, Tassopoulos NC, Papatheodoridis GV, et al. Hepatitis E virus infection in a cohort of patients with acute non-A, non-B hepatitis. J Hepatol 1995; 23: 668-673.
40. Jameel S, Durgapal H, Habibullah CM, Khuroo MS, Panda SK. Enteric non-A, non-B hepatitis: epidemics, animal transmission, and hepatitis E virus detection by the polymerase chain reaction. J Med Virol 1992; 37: 263-270.
41. Tsarev SA, Emerson SU, Tsareva TS, et al. Variation in course of hepatitis E in experimentally infected cynomolgus monkeys. J Infect Dis 1993; 167: 1302-1306.
42. Clayson ET, Innis BL, Myint KS, et al. Detection of hepatitis E virus infections among domestic swine in the Kathmandu Valley of Nepal. Am J Trop Med Hyg 1995; 53: 228-232.
43. Usmanov RK, Balaian MS, Kazachkov Iu A, et al. Further study of experimental hepatitis E in piglets. Vopr Virusol 1994; 39: 208-212.
44. Kabrane-Lazizi Y, Fine JB, Elm J, et al. Evidence for widespread infection of wild rats with hepatitis E virus in the United States. Am J Trop Med Hyg 1999; 61: 331-335.
45. Maneerat Y, Clayson ET, Myint KS, Young GD, Innis BL. Experimental infection of the laboratory rat with the hepatitis E virus. J Med Virol 1996; 48: 121-128.
46. Meng XJ, Purcell RH, Halbur PG, et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci USA 1997; 94: 9860-9865.
47. Meng XJ, Halbur PG, Haynes JS, et al. Experimental infection of pigs with the newly identified swine hepatitis E virus (swine HEV), but not with human strains of HEV. Arch Virol 1998; 143: 1405-1415.
48. Meng XJ, Halbur PG, Shapiro MS, et al. Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol 1998; 72: 9714-9721.
49. Takahashi M, Nishizawa T, Miyajima H, et al. Swine hepatitis E virus strains in Japan form four phylogenetic clusters comparable with those of Japanese isolates of human hepatitis E virus. J Gen Virol 2003; 84: 851-862.
50. Garkavenko O, Obriadina A, Meng J, et al. Detection and characterisation of swine hepatitis E virus in New Zealand. J Med Virol 2001; 65: 525-529.
51. Okamoto H, Takahashi M, Nishizawa T, Fukai K, Muramatsu U, Yoshikawa A. Analysis of the complete genome of indigenous swine hepatitis E virus isolated in Japan. Biochem Biophys Res Commun 2001; 289: 929-936.
52. van der Poel WH, Verschoor F, van der Heide R, et al. Hepatitis E virus sequences in swine related to sequences in humans, The Netherlands. Emerg Infect Dis 2001; 7: 970-976.
53. Yoo D, Willson P, Pei Y, et al. Prevalence of hepatitis E virus antibodies in Canadian swine herds and identification of a novel variant of swine hepatitis E virus. Clin Diagn Lab Immunol 2001; 8: 1213-1219.
54. Wang YC, Zhang HY, Xia NS, et al. Prevalence, isolation, and partial sequence analysis of hepatitis E virus from domestic animals in China. J Med Virol 2002; 67: 516-521.
55. Haqshenas G, Shivaprasad HL, Woolcock PR, Read DH, Meng XJ. Genetic identification and characterization of a novel virus related to human hepatitis E virus from chickens with hepatitis-splenomegaly syndrome in the United States. J Gen Virol 2001; 82: 2449-2462.
56. Huang FF, Haqshenas G, Shivaprasad HL, et al. Heterogeneity and seroprevalence of a newly identified avian hepatitis e virus from chickens in the United States. J Clin Microbiol 2002; 40: 4197-4202.
57. Tei S, Kitajima N, Takahashi K, Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 2003; 362: 371-373.
58. Pina S, Buti M, Cotrina M, Piella J, Girones R. HEV identified in serum from humans with acute hepatitis and in sewage of animal origin in Spain. J Hepatol 2000; 33: 826-833.
59. Schlauder GG, Mushahwar IK. Genetic heterogeneity of hepatitis E virus. J Med Virol 2001; 65: 282-292.
60. Yazaki Y, Mizuo H, Takahashi M, et al. Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food. J Gen Virol 2003; 84: 2351-2357.
61. Yamamoto T, Suzuki H, Toyota T, Takahashi M, Okamoto H. Three male patients with sporadic acute hepatitis E in Sendai, Japan, who were domestically infected with hepatitis E virus of genotype III or IV. J Gastroenterol 2004; 39: 292-298.
62. Clemente-Casares P, Pina S, Buti M, et al. Hepatitis E virus epidemiology in industrialized countries. Emerg Infect Dis 2003; 9: 448-454.
63. Nishizawa T, Takahashi M, Mizuo H, Miyajima H, Gotanda Y, Okamoto H. Characterization of Japanese swine and human hepatitis E virus isolates of genotype IV with 99% identity over the entire genome. J Gen Virol 2003; 84: 1245-1251.
64. Wu JC, Chen CM, Chiang TY, et al. Spread of hepatitis E virus among different-aged pigs: two-year survey in Taiwan. J Med Virol 2002; 66: 488-492.
65. Arankalle VA, Chobe LP, Walimbe AM, Yergolkar PN, Jacob GP. Swine HEV infection in south India and phylogenetic analysis (1985-1999). J Med Virol 2003; 69: 391-396.
66. Arankalle VA, Chobe LP, Joshi MV, Chadha MS, Kundu B, Walimbe AM. Human and swine hepatitis E viruses from Western India belong to different genotypes. J Hepatol 2002; 36: 417-425.
67. Kazachkov Yu A, Balayan MS, Ivannikova TA, et al. Hepatitis E virus in cultivated cells. Arch Virol 1992; 127: 399-402.
68. Huang RT, Li DR, Wei J, Huang XR, Yuan XT, Tian X. Isolation and identification of hepatitis E virus in Xinjiang, China. J Gen Virol 1992; 73: 1143-1148.
69. Huang R, Nakazono N, Ishii K, et al. Hepatitis E virus (87A strain) propagated in A549 cells. J Med Virol 1995; 47: 299-302.
70. Huang R, Li D, Wei S, et al. Cell culture of sporadic hepatitis E virus in China. Clin Diagn Lab Immunol 1999; 6: 729-733.
71. Wei S, Walsh P, Huang R, To SS. 93G, a novel sporadic strain of hepatitis E virus in South China isolated by cell culture. J Med Virol 2000; 61: 311-318.
72. Tam AW, White R, Reed E, et al. In vitro propagation and production of hepatitis E virus from in vivo-infected primary macaque hepatocytes. Virology 1996; 215: 1-9.
73. Tam AW, White R, Yarbough PO, et al. In vitro infection and replication of hepatitis E virus in primary cynomolgus macaque hepatocytes. Virology 1997; 238: 94-102.
74. Panda SK, Nanda SK, Zafrullah M, Ansari IH, Ozdener MH, Jameel S. An Indian strain of hepatitis E virus (HEV): cloning, sequence, and expression of structural region and antibody responses in sera from individuals from an area of high-level HEV endemicity. J Clin Microbiol 1995; 33: 2653-2659.
75. Aye TT, Uchida T, Ma X, et al. Sequence and gene structure of the hepatitis E virus isolated from Myanmar. Virus Genes 1993; 7: 95-109.
76. Reyes GR, Huang CC, Tam AW, Purdy MA. Molecular organization and replication of hepatitis E virus (HEV). Arch Virol Suppl 1993; 7: 15-25.
77. Aye TT, Uchida T, Ma XZ, et al. Complete nucleotide sequence of a hepatitis E virus isolated from the Xinjiang epidemic (1986-1988) of China. Nucleic Acids Res 1992; 20: 3512.
78. Huang CC, Nguyen D, Fernandez J, et al. Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV). Virology 1992; 191: 550-558.
79. Tsarev SA, Emerson SU, Reyes GR, et al. Characterization of a prototype strain of hepatitis E virus. Proc Natl Acad Sci USA 1992; 89: 559-563.
80. Bradley D, Purdy M. Molecular and Serological characteristics of Hepatitis E virus. In Viral Hepatitis and Liver Disease, Nishioka K, Suzuki H, Mishiro S, Oda TS-V (eds). Springer-Verlag: Tokyo, 1994; 42-45.
81. Ray R, Jameel S, Manivel V, Ray R. Indian hepatitis E virus shows a major deletion in the small open reading frame. Virology 1992; 189: 359-362.
82. Dominguez G, Wang CY, Frey TK. Sequence of the genome RNA of rubella virus: evidence for genetic rearrangement during togavirus evolution. Virology 1990; 177: 225-238.
83. Pardigon N, Strauss J. Cellular proteins bind to the 3′ end of Sindbis virus minus-strand RNA. J Virol 1992; 66: 1007-1015.
84. Surjit M, Jameel S, Lal SK. The ORF2 protein of hepatitis E virus binds the 5′ region of viral RNA. J Virol 2004; 78: 320-328.
85. Agrawal S, Gupta D, Panda SK. The 3′ end of hepatitis E virus (HEV) genome binds specifically to the viral RNA-dependent RNA polymerase (RdRp). Virology 2001; 282: 87-101.
86. Tran J, Graff J. Structures and sequences that affect HEV RNA Replication: moving beyond 3′ NCR. 2006. [personel communication]
87. Arankalle VA, Paranjape S, Emerson SU, Purcell RH, Walimbe AM. Phylogenetic analysis of hepatitis E virus isolates from India (1976-1993). J Gen Virol 1999; 80: 1691-1700.
88. Wu JC, Sheen IJ, Chiang TY, et al. The impact of traveling to endemic areas on the spread of hepatitis E virus infection: epidemiological and molecular analyses. Hepatology 1998; 27: 1415-1420.
89. Hsieh SY, Yang PY, Ho YP, Chu CM, Liaw YF. Identification of a novel strain of hepatitis E virus responsible for sporadic acute hepatitis in Taiwan. J Med Virol 1998; 55: 300-304.
90. Huang R, Nakazono N, Ishii K, Kawamata O, Kawaguchi R, Tsukada Y. Existing variations on the gene structure of hepatitis E virus strains from some regions of China. J Med Virol 1995; 47: 303-308.
91. Wang Y, Ling R, Erker JC, et al. A divergent genotype of hepatitis E virus in Chinese patients with acute hepatitis. J Gen Virol 1999; 80: 169-177.
92. Riddell MA, Li F, Anderson DA. Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using monoclonal antibodies. J Virol 2000; 74: 8011-8017.
93. Worm H, van der Poel W, Brandstatter G. Hepatitis E: an overview. Microbes Infect 2002; 4: 657-666.
94. Ando T, Noel JS, Fankhauser RL. Genetic classification of 'Norwalk-like viruses.' J Infect Dis 2000; 181: S336-S348.
95. Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol 2006;16: 5-36.
96. van Cuyck H, Juge F, Roques P. Phylogenetic analysis of the first complete hepatitis E virus (HEV) genome from Africa. FEMS Immunol Med Microbiol 2003; 39: 133-139.
97. Schlauder GG, Dawson GJ, Erker JC, et al. The sequence and phylogenetic analysis of a novel hepatitis E virus isolated from a patient with acute hepatitis reported in the United States. J Gen Virol 1998; 79: 447-456.
98. Ansari IH, Nanda SK, Durgapal H, et al. Cloning, sequencing, and expression of the hepatitis E virus (HEV) nonstructural open reading frame 1 (ORF1). J Med Virol 2000; 60: 275-283.
99. Ropp SL, Tam AW, Beames B, Purdy M, Frey TK. Expression of the hepatitis E virus ORF1. Arch Virol 2000; 145: 1321-1337.
100. Sehgal D, Thomas S, Chakraborty M, Jameel S. Expression and processing of the Hepatitis E virus ORF 1 nonstructural polyprotein. Virology 2006; 3: 38.
101. Rozanov M, Koonin E, Gorbalenya A. Conservation of the putative methyltransferase domain: a hallmark of the 'Sindbis-like' supergroup of positive-strand RNA viruses. J Gen Virol 1992; 73: 2129-2134.
102. Magden J, Takeda N, Li T, et al. Virus-specific mRNA capping enzyme encoded by hepatitis E virus. J Virol 2001; 75: 6249-6255.
103. Krausslich H, Nicklin M, Lee C, Wimmer E. Polyprotein processing in Picornavirus replication. Biochimie 1988; 70: 119-130.
104. Gorbalenya A, Donchenko A, Blinov V, Koonin E. Cysteine proteases of positive strand RNA viruses and chymotrypsin-like serine proteases. A distinct protein superfamily with a common structural fold. FEBS Lett 1989a; 243: 103-114.
105. Gorbalenya A, Koonin E, Lai M. Putative papain-related thiol proteases of positive-strand RNA viruses. Identification of rubi- and aphthovirus proteases and delineation of a novel conserved domain associated with proteases of rubi-, alpha- and coronaviruses. FEBS Lett 1991; 288: 201-205.
106. Spall Valerie E, Shanks M, Lomonossoff G. Polyprotein Processing as a Strategy for Gene Expression in RNA Viruses. Seminars in Virology 1997; 8: 15-23.
107. Bouffard P, Bartenschlager R, Ahlborn-Laake L, Mous J, Roberts N, Jacobsen H. An in vitro assay for hepatitis C virus NS3 serine proteinase. Virology 1995; 209: 52-59.
108. Bonilla P, SA H, Pinon J, Weiss S. Characterization of the leader papain-like proteinase of MHV-A59 identification of a new in vitro cleavage site. Virology 1995 209: 489-497.
109. Gorbalenya A, Koonin E, Donchenko A, Blinov V. A novel superfamily of nucleoside triphosphate-binding motif containing proteins which are probably involved in duplex unwinding in DNA and RNA replication and recombination. FEBS Lett 1988; 235: 16-24.
110. Gorbalenya A, Blinov V, Donchenko A, Koonin E. An NTP-binding motif is the most conserved sequence in a highly diverged monophyletic group of proteins involved in positive strand RNA viral replication. J Mol Evol 1989b; 28: 256-268.
111. Geider K, Hoffmann-Berling H. Proteins controlling the helical structure of DNA. Annu Rev Biochem 1981; 50: 233-260.
112. Fry KE, Tam AW, Smith MM, et al. Hepatitis E virus (HEV): strain variation in the nonstructural gene region encoding consensus motifs for an RNA-dependent RNA polymerase and an ATP/GTP binding site. Virus Genes 1992; 6: 173-185.
113. Koonin E. The phylogeny of RNA-dependent RNA polymerases of positive-strand RNA viruses. J Gen Virol 1991; 72: 2197-2206.
114. Graff J, Nguyen H, Yu C, et al. The open reading frame 3 gene of hepatitis E virus contains a cis-reactive element and encodes a protein required for infection of macaques. J Virol 2005; 79: 6680-6689.
115. Hansen J, Long A, Schultz S. Structure of the RNA-dependent RNA polymerase of poliovirus. Structure 1997; 5: 1109-1122.
116. Ago H, Adachi T, Yoshida A, et al. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Structure Fold Des 1999; 7: 1417-1426.
117. Kaur M, Hyams KC, Purdy MA, et al. Human linear B-cell epitopes encoded by the hepatitis E virus include determinants in the RNA-dependent RNA polymerase. Proc Natl Acad Sci USA 1992; 89:3855-3858.
118. Khudyakov YuE, Favorov MO, Jue DL, Hine TK, Fields HA. Immunodominant antigenic regions in a structural protein of the hepatitis E virus. Virology 1994; 198: 390-393.
119. Yarbough PO, Tam AW, Fry KE, et al. Hepatitis E virus: identification of type-common epitopes. J Virol 1991; 65: 5790-5797.
120. Jameel S, Zafrullah M, Ozdener MH, Panda SK. Expression in animal cells and characterization of the hepatitis E virus structural proteins. J Virol 1996; 70: 207-216.
121. Torresi J, Meanger J, Lambert P, Li F, Locarnini SA, Anderson DA. High level expression of the capsid protein of hepatitis E virus in diverse eukaryotic cells using the Semliki Forest virus replicon. J Virol Methods 1997; 69: 81-91.
122. Torresi J, Li F, Locarnini SA, Anderson DA. Only the non-glycosylated fraction of hepatitis E virus capsid (open reading frame 2) protein is stable in mammalian cells. J Gen Virol 1999; 80: 1185-1188.
123. Robinson RA, Burgess WH, Emerson SU, et al. Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells. Protein Expr Purif 1998; 12: 75-84.
124. McAtee CP, Zhang Y, Yarbough PO, Bird T, Fuerst TR. Purification of a soluble hepatitis E open reading frame 2-derived protein with unique antigenic properties. Protein Expr Purif 1996; 8: 262-270.
125. Carl M, Isaacs SN, Kaur M, et al. Expression of hepatitis E virus putative structural proteins in recombinant vaccinia viruses. Clin Diagn Lab Immunol 1994; 1: 253-256.
126. Tyagi S, Jameel S, Lal SK. Self-association and mapping of the interaction domain of hepatitis E virus ORF3 protein. J Virol 2001; 75: 2493-2498.
127. Tyagi S, Jameel S, Lal SK. A yeast two-hybrid study on self-association of the ORF2 protein of hepatitis E virus. Biochem Biophys Res Commun 2001; 284: 614-621.
128. Zafrullah M, Ozdener MH, Kumar R, Panda SK, Jameel S. Mutational analysis of glycosylation, membrane translocation, and cell surface expression of the hepatitis E virus ORF2 protein. J Virol 1999; 73: 4074-4082.
129. McAtee CP, Zhang Y, Yarbough PO, et al. Purification and characterization of a recombinant hepatitis E protein vaccine candidate by liquid chromatography-mass spectrometry. J Chromatogr B Biomed Appl 1996; 685: 91-104.
130. Zhang Y, McAfee P, Yarbough PO, Tam AW, Fuerst T. Expression, characterization, and immunoreactivities of a soluble hepatitis E virus putative capsid protein species expressed in insect cells. Clin Diagn Lab Immunol 1997; 4: 423-428.
131. Li TC, Yamakawa Y, Suzuki K, et al. Expression and self-assembly of empty virus-like particles of hepatitis E virus. J Virol 1997; 71: 7207-7213.
132. Xing L, Kato K, Li T, et al. Recombinant hepatitis E capsid protein self-assembles into a dual-domain T = I particle presenting native virus epitopes. Virology 1999; 265: 35-45.
133. Xiaofang L, Zafrullah M, Ahmad F, Jameel S. A C-Terminal Hydrophobic Region is Required for Homo-Oligomerization of the Hepatitis E Virus Capsid (ORF2) Protein. J Biomed Biotechnol 2001; 1: 122-128.
134. Zafrullah M, Ozdener MH, Panda SK, Jameel S. The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton. J Virol 1997; 71: 9045-9053.
135. Pawson T. Protein modules and signalling networks. Nature 1995; 373: 573-580.
136. Cohen G, Ren R, Baltimore D. Modular binding domains in signal transduction proteins. Cell 1995; 80: 237-248.
137. Korkaya H, Jameel S, Gupta D, et al. The ORF3 protein of hepatitis E virus binds to Src homology 3 domains and activates MAPK. J Biol Chem 2001; 276: 42389-42400.
138. Feng S, Chen J, Yu H, Simon J, Schreiber S. Two binding orientations for peptides to the Src SH3 domain development of a general model for SH3-ligand interactions. Science 1994; 266: 1241-1247.
139. Yu H, Chen J, Feng S, Dalgarno D, Brauer A, Schreiber S. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 1994; 76: 933-945.
140. Krajcsi P, Wold WS. Viral proteins that regulate cellular signalling. J Gen Virol 1998; 79: 1323-1335.
141. Shimamura A, Ballif B, Richards S, Blenis J. Rsk1 mediates a MEK-MAP kinase cell survival signal. Curr Biol 2000; 10: 127-135.
142. Benn J, Schneider R. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras// Raf// MAP kinase signaling cascade. Proc Natl Acad Sci USA 1994; 91: 10350-10354.
143. Hayashi J, Aoki H, Kajino K, Moriyama M, Arakawa Y, Hino O. Hepatitis C virus core protein activates the MAPK/ERK cascade synergistically with tumor promoter TPA, but not with epidermal growth factor or transforming growth factor alpha. Hepatology 2000; 32: 958-961.
144. Fukuda K, Tsuchihara K, Hijikata M, Nishiguchi S, Kuroki T, Shimotohno K. Hepatitis C virus core protein enhances the activation of the transcription factor, Elk1, in response to mitogenic stimuli. Hepatology 2001; 33: 159-165.
145. Tyagi S, Korkaya H, Zafrullah M, Jameel S, Lal SK. The phosphorylated form of the ORF3 protein of hepatitis E virus interacts with its non-glycosylated form of the major capsid protein, ORF2. J Biol Chem 2002; 277: 22759-22767.
146. Emerson S, Nguyen H, Torian U, Purcell R. ORF3 protein of hepatitis E virus is not required for replication, virion assembly or infection of 10-3 hepatoma cells in vitro. 2006. [personal communication].
147. Kawai HF, Koji T, lida F, Kaneko S, Kobayashi K, Nakane PK. Shift of hepatitis E virus RNA from hepatocytes to biliary epithelial cells during acute infection of rhesus monkey. J Viral Hepat 1999; 6: 287-297.
148. Williams TP, Kasorndorkbua C, Halbur PG, et al. Evidence of extrahepatic sites of replication of the hepatitis E virus in a swine model. J Clin Microbiol 2001; 39: 3040-3046.
149. Nanda SK, Panda SK, Durgapal H, Jameel S. Detection of the negative strand of hepatitis E virus RNA in the livers of experimentally infected rhesus monkeys: evidence for viral replication. J Med Virol 1994; 42: 237-240.
150. Levis R, Schlesinger S, Huang HV. Promoter for Sindbis virus RNA-dependent subgenomic RNA transcription. J Virol 1990; 64: 1726-1733.
151. Xia X, Huang R, Li D. Studies on the subgenomic RNAs of hepatitis E virus. Wei Sheng Wu Xue Bao 2000; 40: 622-627.
152. Graff J, Torian U, Nguyen H, Emerson SU. A Bicistronic Subgenomic mRNA Encodes both the ORF 2 and ORF 3 Proteins of Hepatitis E Virus. J Virol 2006; 80: 5919-5926.
153. Meng XJ. Swine hepatitis E virus: cross-species infection and risk in xenotransplantation. Curr Top Microbiol Immunol 2003; 278: 185-216.
154. Huang FF, Pierson FW, Toth TE, Meng XJ. Construction and characterization of infectious cDNA clones of a chicken strain of hepatitis E virus (HEV), avian HEV. J Gen Virol 2005; 86: 2585-2593.
155. Emerson SU, Zhang M, Meng XJ, et al. Recombinant hepatitis E virus genomes infectious for primates: importance of capping and discovery of a cis-reactive element. Proc Natl Acad Sci USA 2001; 98: 15270-15275.
156. Emerson SU, Nguyen H, Graff J, Stephany DA, Brockington A, Purcell RH. In vitro replication of hepatitis E virus (HEV) genomes and of an HEV replicon expressing green fluorescent protein. J Virol 2004; 78: 4838-4846.
157. Aye TT, Uchida T, Ma X, et al. Sequence comparison of the capsid region of hepatitis E viruses isolated from Myanmar and China. Microbiol Immunol 1992; 36: 615-621.
158. Thakral D, Nayak B, Rehman S, Durgapal H, Panda SK. Replication of a recombinant hepatitis E virus genome tagged with reporter genes and generation of a short-term cell line producing viral RNA and proteins. J Gen Virol 2005; 86: 1189-1200.
159. Belabbes E, Bouguermouh A, Benatallah A, Illoul G. Epidemic non-A//non-B viral hepatitis in Algeria: strong evidence for its spreading by water. J Med Virol 1985; 16: 257-263.
160. Sarthou JL, Budkowska A, Sharma MD, Lhuillier M, Pillot J. Characterization of an antigen-antibody system associated with epidemic non-A, non-B hepatitis in West Africa and experimental transmission of an infectious agent to primates. Annales de l'Institut Pasteur. Virologie 1986; 137: 225-232.
161. Morrow R, Smetana H, Sai F, Edgcomb J. Unusual features of viral hepatitis in Accra, Ghana. Ann Intern Med 1986; 68: 1250-1262.
162. Tsega E, Krawczynski K, Hansson BG, et al. Outbreak of acute hepatitis E virus infection among military personnel in northern Ethiopia. J Med Virol 1991; 34: 232-236.
163. Bile K, Isse A, Mohamud O, et al. Contrasting roles of rivers and wells as sources of drinking water on attack and fatality rates in a hepatitis E epidemic in Somalia. Am J Trop Med Hyg 1994; 51: 466-474.
164. Isaacson M, Frean J, He J, Seriwatana J, Innis BL. An outbreak of hepatitis E in Northern Namibia, 1983. Am J Trop Med Hyg 2000; 62: 619-625.
165. De Cock K, Bradley D, Sandford N, Govindarajan S, Maynard J, Redeker A. Epidemic non-A, non-B hepatitis in patients from Pakistan. Ann Intern Med 1987; 106: 227-230.
166. Iqbal M, Ahmed A, Qamar A, et al. An outbreak of enterically transmitted non-A, non-B hepatitis in Pakistan. Am J Trop Med Hyg 1989; 40: 438-443.
167. Bryan JP, Tsarev SA, Iqbal M, et al. Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. J Infect Dis 1994; 170: 517-521.
168. Hla M, Myint Myint S, Tun K, et al. A clinical and epidemiological study of an epidemic of non-A non-B hepatitis in Rangoon. Am J Trop Med Hyg 1985; 34: 1183-1189.
169. Uchida T, Aye TT, Ma X, et al. An epidemic outbreak of hepatitis E in Yangon of Myanmar: antibody assay and animal transmission of the virus. Acta Pathol Jpn 1993; 43: 94-98.
170. Zhuang H, Cao XY, Liu CB, Wang GM. Epidemiology of hepatitis E in China. Gastroenterol Jpn 1991; 26: 135-138.
171. Bi SL, Purdy MA, McCaustland KA, Margolis HS, Bradley DW. The sequence of hepatitis E virus isolated directly from a single source during an outbreak in China. Virus Res 1993; 28: 233-247.
172. Corwin AL, Khiem HB, Clayson ET, et al. A waterborne outbreak of hepatitis E virus transmission in southwestern Vietnam. Am J Trop Med Hyg 1996; 54: 559-562.
173. Fortier D, Tread well T, Koff R. Enterically transmitted non-A, non-B hepatitis importation from Mexico to Massachusetts. N Engl J Med 1989; 320: 1281-1282.
174. Velazquez O, Stetler H, Avila C, et al. Epidemic transmission of enterically transmitted non-A, non-B hepatitis in Mexico, 1986-1987. JAMA 1990. 263: 3281-3285.
175. Bader TF, Krawczynski K, Polish LB, Favorov MO. Hepatitis E in a U.S. traveler to Mexico. N Engl J Med 1991; 325: 1659.
176. Dawson GJ, Mushahwar IK, Chau KH, Gitnick GL. Detection of long-lasting antibody to hepatitis E virus in a US traveller to Pakistan. Lancet 1992; 340: 426-427.
177. Skidmore SJ, Yarbough PO, Gabor KA, Tam AW, Reyes GR, Flower AJ. Imported hepatitis E in UK. Lancet 1991; 337: 1541.
178. Skidmore SJ, Sherratt LM. Hepatitis E infection in the UK. J Viral Hepat 1996; 3: 103-105.
179. Zaaijer HL, Kok M, Lelie PN, Timmerman RJ, Chau K, van der Pal HJ. Hepatitis E in The Netherlands: imported and endemic. Lancet 1993; 341: 826.
180. Chapman BA, Burt MJ, Wilkinson ID, Schousboe MI. Community acquired viral hepatitis in New Zealand: a case of sporadic hepatitis E virus infection. Aust NZ J Med 1993; 23: 722-723.
181. Jardi R, Buti M, Rodriguez-Frias F, Esteban R. Hepatitis E infection in acute sporadic hepatitis in Spain. Lancet 1993; 341: 1355-1356.
182. Buti M, Jardi R, Cotrina M, et al. Hepatitis E virus infection in acute hepatitis in Spain. J Virol Methods 1995; 55: 49-54.
183. Tassopoulos NC, Krawczynski K, Hatzakis A, et al. Case report: role of hepatitis E virus in the etiology of community-acquired non-A, non-B hepatitis in Greece. J Med Virol 1994; 42: 124-128.
184. Zanetti AR, Dawson GJ. Hepatitis type E in Italy: a seroepidemiological survey. Study Group of Hepatitis E. J Med Virol 1994; 42: 318-320.
185. Coursaget P, Depril N, Buisson Y, Molinie C, Roue R. Hepatitis type E in a French population: detection of anti-HEV by a synthetic peptide-based enzyme-linked immunosorbent assay. Res Virol 1994; 145: 51-57.
186. Heath TC, Burrow JN, Currie BJ, et al. Locally acquired hepatitis E in the Northern Territory of Australia. Med J Aust 1995; 162:
187. Moaven L, Van Asten M, Crofts N, Locarnini SA. Seroepidemiology of hepatitis E in selected Australian populations. J Med Virol 1995; 45: 326-330.
188. Karetnyi YV, Favorov MO, Khudyakova NS, et al. Serological evidence for hepatitis E virus infection in Israel. J Med Virol 1995; 45: 316-320.
189. Rey JA, Findor JA, Daruich JR, et al. Prevalence of IgG Anti-HEV in Buenos Aires, a Nonendemic Area for Hepatitis E. J Travel Med 1997; 4: 100-101.
190. Worm HC, Wurzer H, Frosner G. Sporadic hepatitis E in Austria. N Engl J Med 1998; 339: 1554-1555.
191. Takahashi M, Nishizawa T, Yoshikawa A, et al. Identification of two distinct genotypes of hepatitis E virus in a Japanese patient with acute hepatitis who had not travelled abroad. J Gen Virol 2002; 83: 1931-1940.
192. Tokita H, Harada H, Gotanda Y, Takahashi M, Nishizawa T, Okamoto H. Molecular and serological characterization of sporadic acute hepatitis E in a Japanese patient infected with a genotype III hepatitis E virus in 1993. J Gen Virol 2003; 84: 421-427.
193. Aggarwal R, Shahi H, Naik S, Yachha SK, Naik SR. Evidence in favour of high infection rate with hepatitis E virus among young children in India. J Hepatol 1997; 26: 1425-1426.
194. Arora NK, Panda SK, Nanda SK, et al. Hepatitis E infection in children: study of an outbreak. J Gastroenterol Hepatol 1999; 14: 572-577.
195. Khuroo MS, Teli MR, Skidmore S, Sofi MA, Khuroo MI. Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981; 70: 252-255.
196. Khuroo M, Kamili S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat 2003; 10: 61-69.
197. Panda S, Jameel S. Hepatitis E virus from Epidemiology to Molecular Biology. Viral Hepatitis Reviews 1997; 3: 227-251.
198. Panda SK, Acharya SK. Hepatitis E virus infection: where are we? Natl Med J India 1998; 11: 56-58.
199. Emerson SU, Purcell RH. Running like water-the omnipresence of hepatitis E. N Engl J Med 2004; 351: 2367-2368.
200. Jothikumar N, Aparna K, Kamatchiammal S, Paulmurugan R, Saravanadevi S, Khanna P. Detection of hepatitis E virus in raw and treated wastewater with the polymerase chain reaction. Appl Environ Microbiol 1993; 59: 2558-2562.
201. Pina S, Jofre J, Emerson SU, Purcell RH, Girones R. Characterization of a strain of infectious hepatitis E virus isolated from sewage in an area where hepatitis E is not endemic. Appl Environ Microbiol 1998; 64: 4485-4488.
202. Ray R, Aggarwal R, Salunke PN, Mehrotra NN, Talwar GP, Naik SR. Hepatitis E virus genome in stools of hepatitis patients during large epidemic in north India. Lancet 1991; 338: 783-784.
203. Chauhan A, Dilawari J, Jameel S, et al. Common aetiological agent for epidemic and sporadic non-A, non-B hepatitis. Lancet 1992; 339: 1509-1510.
204. Naik SR, Aggarwal R, Salunke PN, Mehrotra NN. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ 1992; 70: 597-604.
205. Hla M, Myint MS, Tun K, Thein-Maung M, Khin MT. A clinical and epidemiological study of an epidemic of non-A non-B hepatitis in Rangoon. Am J Trop Med Hyg 1985; 34: 1183-1189.
206. Mast E, Polish L, Favorov M, et al. Hepatitis E among refugees in Kenya: minimal apparent person-to-person transmission, evidence of age-dependent disease expression, and new serological assays. In Viral hepatitis and Liver Disease, Nishioka K, Suzuki H, Mishiro S, Oda T (eds).Springer-Verlag: Tokyo, 1994; 375-378.
207. Matsuda H, Okada K, Takahashi K, Mishiro S. Severe hepatitis E virus infection after ingestion of uncooked liver from a wild boar. J Infect Dis 2003; 188: 944.
208. Ishikawa K, Matsui K, Madarame T, Sato S, Oikawa K, Uchida T. Hepatitis E probably contracted via a Chinese herbal medicine, demonstrated by nucleotide sequencing. J Gastroenterol 1995; 30: 534-538.
209. Nanda SK, Ansari IH, Acharya SK, Jameel S, Panda SK. Protracted viremia during acute sporadic hepatitis E virus infection. Gastroenterology 1995; 108: 225-230.
210. Banas B, Tausch U, Hofstädter F, et al. First Report of a Chronic Course and Molecular Characterization of the Virus. 2006. [personal communication].
211. Robson SC, Adams S, Brink N, Woodruff B, Bradley D. Hospital outbreak of hepatitis E. Lancet 1992; 339: 1424-1425.
212. Chauhan A, Jameel S, DiIawari JB, Chawla YK, Kaur U, Ganguly NK. Hepatitis E virus transmission to a volunteer. Lancet 1993; 341: 149-150.
213. Wang CH, Flehmig B, Moeckli R. Transmission of hepatitis E virus by transfusion? Lancet 1993; 341: 825-826.
214. Halfon P, Ouzan D, Chanas M, et al. High prevalence of hepatitis E virus antibody in haemodialysis patients. Lancet 1994; 344: 746.
215. Lavanchy D, Morel B, Frei PC. Seroprevalence of hepatitis E virus in Switzerland. Lancet 1994; 344: 747-748.
216. Datta R, Panda S, Tandon B, et al. Acute sporadic non A-non B viral hepatitis on India epidemiological and immunological studies. J Gastroenterol Hepatol 1987; 2: 335-348.
217. Panda S, Datta R, Kaur J, Zuckerman A, Nayak N. Enterically transmitted non-A, non-B hepatitis recovery of virus-like particles from an epidemic in south Delhi and transmission studies in rhesus monkeys. Hepatology 1989b; 10: 466-472.
218. Khuroo MS, Kamili S, Jameel S. Vertical transmission of hepatitis E virus. Lancet 1995; 345: 1025-1026.
219. Kumar RM, Uduman S, Rana S, Kochiyil JK, Usmani A, Thomas L. Sero-prevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Gynecol Reprod Biol 2001; 100: 9-15.
220. Singh S, Mohanty A, Joshi YK, Deka D, Mohanty S, Panda SK. Mother-to-child transmission of hepatitis E virus infection. Indian J Pediatr 2003; 70: 37-39.
221. Montella F, Rezza G, Di Sora F, Pezzotti P, Recchia O. Association between hepatitis E virus and HIV infection in homosexual men. Lancet 1994; 344: 1433.
222. Goldsmith R, Yarbough PO, Reyes GR, et al. Enzyme-linked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian children. Lancet 1992; 339: 328-331.
223. Nanda SK, Yalcinkaya K, Panigrahi AK, Acharya SK, Jameel S, Panda SK. Etiological role of hepatitis E virus in sporadic fulminant hepatitis. J Med Virol 1994; 42: 133-137.
224. Khuroo M, Saleem M, Teli M, Sofi M. Failure to detect chronic liver disease after epidemic non-A, non-B hepatitis. Lancet 1980b; 2: 97-98.
225. Zhuang H, Cao X, Liu C, Wang G: Enterically transmitted non-A, non-B hepatitis in China. In Viral hepatitis C, D and E, Shikata T, Purcell R, Uchida T (eds). Elsevier Science: Amsterdam, 1991; 277-285.
226. Dienstag J. Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterol 1983; 85: 439-462.
227. Smith JL. A review of hepatitis E virus. J Food Prot 2001; 64: 572-586.
228. Clayson ET, Myint KS, Snitbhan R, et al. Viremia, fecal shedding, and IgM and IgG responses in patients with hepatitis E. J Infect Dis 1995; 172: 927-933.
229. Takahashi M, Nishizawa T, Tanaka T, Tsatsralt-Od B, Inoue J, Okamoto H. Correlation between positivity for immunoglobulin A antibodies and viraemia of swine hepatitis E virus observed among farm pigs in Japan. J Gen Virol 2005; 86: 1807-1813.
230. Tian D, Chen Y, Xia N. Significance of serum IgA in patients with acute hepatitis E virus infection. World J Gastroenterol 2006; 12: 3919-3923.
231. Longer CF, Denny SL, Caudill JD, et al. Experimental hepatitis E: pathogenesis in cynomolgus macaques (Macaca fascicularis). J Infect Dis 1993; 168: 602-609.
232. Hamid S, Jafri S, Khan H, Shah H, Abbas Z, Fields H. Fulminant hepatic failure in pregnant women acute fatty liver or acute viral hepatitis? J Hepatol 1996; 25: 20-27.
233. Arora NK, Nanda SK, Gulati S, et al. Acute viral hepatitis types E, A, and B singly and in combination in acute liver failure in children in north India. J Med Virol 1996; 48: 215-221.
234. Acharya SK, Dasarathy S, Panda SK. A prospective evaluation of outcome of fulminant hepatitis in pregnancy related to hepatitis E virus. In Hepatitis E Virus: epidemiology to Candidate Vaccine, Tandon BN, Acharya SK (eds). Trop Gastroenterol, 1996; 102-118.
235. Skidmore SJ, Yarbough PO, Gabor KA, Reyes GR. Hepatitis E virus: the cause of a waterbourne hepatitis outbreak. J Med Virol 1992; 37: 58-60.
236. Kumar A, Aggarwal R, Naik SR, Saraswat V, Ghoshal UC, Naik S. Hepatitis E virus is responsible for decompensation of chronic liver disease in an endemic region. Indian J Gastroenterol 2004; 23: 59-62.
237. Sallie R, Chiyende J, Tan KC, et al. Fulminant hepatic failure resulting from coexistent Wilson's disease and hepatitis E. Gut 1994; 35: 849-853.
238. Arankalle VA, Chadha MS, Banerjee K, Srinivasan MA, Chobe LP. Hepatitis E virus infection in pregnant rhesus monkeys. Indian J Med Res 1993; 97: 4-8.
239. Krawczynski K, Bradley D. Enterically transmitted non-A, non-B hepatitis identification of virus-associated antigen in experimentally infected cynomolgus macaques. J Infect Dis 1989; 159: 1042-1049.
240. Hussaini SH, Skidmore SJ, Richardson P, Sherratt LM, Cooper BT, O'Grady JG. Severe hepatitis E infection during pregnancy. J Viral Hepat 1997; 4: 51-54.
241. Khudyakov YE, Lopareva EN, Jue DL, Crews TK, Thyagarajan SP, Fields HA. Antigenic domains of the open reading frame 2-encoded protein of hepatitis E virus. J Clin Microbiol 1999; 37: 2863-2871.
242. Tsarev SA, Tsareva TS, Emerson SU, et al. ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates. J Infect Dis 1993; 168: 369-378.
243. Li TC, Zhang J, Shinzawa H, et al. Empty virus-like particle-based enzyme-linked immunosorbent assay for antibodies to hepatitis E virus. J Med Virol 2000; 62: 327-333.
244. Ghabrah TM, Tsarev S, Yarbough PO, Emerson SU, Strickland GT, Purcell RH. Comparison of tests for antibody to hepatitis E virus. J Med Virol 1998; 55: 134-137.
245. Favorov MO, Fields HA, Purdy MA, et al. Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J Med Virol 1992; 36: 246-250.
246. Khuroo MS, Rustgi VK, Dawson GJ, et al. Spectrum of hepatitis E virus infection in India. J Med Virol 1994; 43: 281-286.
247. Lin CC, Wu JC, Chang TT, et al. Diagnostic value of immunoglobulin G (IgG) and IgM anti-hepatitis E virus (HEV) tests based on HEV RNA in an area where hepatitis E is not endemic. J Clin Microbiol 2000; 38: 3915-3918.
248. Aggarwal R, Kumar R, Pal R, Naik S, Semwal SN, Naik SR. Role of travel as a risk factor for hepatitis E virus infection in a disease-endemic area. Indian J Gastroenterol 2002; 21: 14-18.
249. Chobe LP, Chadha MS, Banerjee K, Arankalle VA. Detection of HEV RNA in faeces, by RT-PCR during the epidemics of hepatitis E in India (1976-1995). J Viral Hepat 1997; 4: 129-133.
250. Pina S, Buti M, Cotrina M, Piella J, Girones R. HEV identified in serum from humans with acute hepatitis and in sewage of animal origin in Spain. J Hepatol 2000; 33: 826-833.
251. Tsarev SA, Tsareva TS, Emerson SU, et al. Infectivity titration of a prototype strain of hepatitis E virus in cynomolgus monkeys. J Med Virol 1994; 43: 135-142.
252. Arankalle VA, Chadha MS, Chobe LP, Nair R, Banerjee K. Cross-challenge studies in rhesus monkeys employing different Indian isolates of hepatitis E virus. J Med Virol 1995; 46: 358-363.
253. Jothikumar N, Cromeans TL, Robertson BH, Meng XJ, Hill VR. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J Virol Methods 2006; 131: 65-71.
254. Aggarwal R, Kini D, Sofat S, Naik SR, Krawczynski K. Duration of viraemia and faecal viral excretion in acute hepatitis E. Lancet 2000; 356: 1081-1082.
255. McCaustland KA, Krawczynski K, Ebert JW, et al. Hepatitis E virus infection in chimpanzees: a retrospective analysis. Arch Virol 2000; 145: 1909-1918.
256. Khuroo MS, Dar MY. Hepatitis E: evidence for person-to-person transmission and inability of low dose immune serum globulin from an Indian source to prevent it. Indian J Gastroenterol 1992; 11: 113-116.
257. Tsarev SA, Tsareva TS, Emerson SU, et al. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci USA 1994; 91: 10198-10202.
258. Arankalle VA, Chadha MS, Tsarev SA, et al. Seroepidemiology of Water-Borne Hepatitis in India and Evidence for a Third Enterically-Transmitted Hepatitis Agent. Proc Natl Acad Sci USA 1994; 91: 3428-3432.
259. Purdy MA, McCaustland KA, Krawczynski K, Spelbring J, Reyes GR, Bradley DW. Preliminary evidence that a trpE-HEV fusion protein protects cynomolgus macaques against challenge with wild-type hepatitis E virus (HEV). J Med Virol 1993; 41: 90-94.
260. Khudyakov Yu E, Khudyakova NS, Jue DL, Wells TW, Padhya N, Fields HA. Comparative characterization of antigenic epitopes in the immunodominant region of the protein encoded by open reading frame 3 in Burmese and Mexican strains of hepatitis E virus. J Gen Virol 1994; 75: 641-646.
261. Tsarev SA, Tsareva TS, Emerson SU, et al. Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge. Vaccine 1997; 15: 1834-1838.
262. Panda S, Nanda S, Durgapal H, et al. Diagnostic and protective immune status of hepatitis E virus structural antigens. In Viral Hepatitis and Liver Diseases, Rizzetto M, Putcell R, Gerin J, Verme G (eds). Edizioni Minerva Medica: Turin, 1997; 321-326.
263. Fuerst TR, Yarbough PO, Zhang Y, et al. Prevention of hepatitis E using a novel ORF2-2 subunit vaccine. In Enterically transmitted hepatitis viruses, Buisson Y, Coursaget P, Kane M (eds). Joue-les-Tours: La Simarre: 1996; 384-392.
264. Yarbough P, Krawczynski K, Tam A, et al. Prevention of hepatitis E using r62K subunit vaccine: Full protection against heterologous HEV challenge in cynomolgus macaques. In Viral hepatitis and Liver disease, Rizetto M, Purcell R, Gerin J, Verme G (eds). Minerva Medica: Turin, 1997; 650-655.
265. Im SW, Zhang JZ, Zhuang H, et al. A bacterially expressed peptide prevents experimental infection of primates by the hepatitis E virus. Vaccine 2001; 19: 3726-3732.
266. Stevenson P. Nepal calls the shots in hepatitis E virus vaccine trial. Lancet 2000; 355: 1623.
267. He J, Hoffman SL, Hayes CG. DNA inoculation with a plasmid vector carrying the hepatitis E virus structural protein gene induces immune response in mice. Vaccine 1997; 15: 357-362.
268. He J, Hayes CG, Binn LN, et al. Hepatitis E virus DNA vaccine elicits immunologic memory in mice. J Biomed Sci 2001; 8: 223-226.
269. Li T, Takeda N, Miyamura T. Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice. Vaccine 2001; 19: 3476-3484.
270. Arankalle V, Deshmukh T, Loie K, Shaligram, Kapre S. Challenge studies in rhesus monkeys immunized using DNA, DNA-primed-protein-boost and encapsulation of DNA and protein in liposome-based approaches. J Clin Virol 2006; 36: S237.
271. Shrestha M, Scott R, Joshi D, et al. Protection against hepatitis E by a recombinant vaccine. J Clin Virol. 2006; 36: S2.
272. Acharya S, Batra Y, Bhatkal B, et al. Seroepidemiology of hepatitis A virus infection among school children in Delhi and north Indian patients with chronic liver disease implications for HAV vaccination. J Gastroenterol Hepatol 2003; 18: 822-827.